Just 25 years ago, venous thromboembolism treatment regimens were primitive, writes Dr Holley. But two trials showed that apixaban and rivaroxaban are proving excellent options for tackling VTE.

The thrombosis risk remains elevated despite adequate prophylaxis. All patients undergoing major abdominal surgery for malignant disease should, therefore, receive thromboprophylaxis using UFH ...

Our search strategy focused on key terms that corresponding to the predefined main domains of cost-effectiveness analysis, cancer, thrombosis ... using low-dose aspirin, which was found to be both ...